基于安达卢西亚患者学校方法的联合教学干预控制抗凝患者凝血酶原时间的随机对照试验方案
本研究为在西班牙马拉加某医疗区初级保健中心开展的随机对照试验方案,拟纳入312例口服维生素K拮抗剂且INR治疗范围内时间≤65%的患者,比较由受训抗凝患者实施「同伴间」联合教学干预与常规临床实践对INR控制的效果,主要检测组间INR差异≥15%。
要点
- 针对INR控制不佳的口服抗凝患者,采用患者间联合教学干预。
- 主要评价指标为干预前后治疗范围内时间及INR值变化。
- 计划样本312例,每组156例,以检测组间INR差异≥15%。
核心结论
- 方案拟验证由受训抗凝患者实施的联合教学干预能否改善口服维生素K拮抗剂患者的INR控制。
研究设计与样本
- 随机对照试验,在西班牙马拉加一个医疗区的初级保健中心开展。
- 研究人群为参加口服维生素K拮抗剂治疗项目的患者。
- 第一步识别INR治疗范围内时间≤65%的患者,第二步将INR控制值低于2或高于3者分组。
- 计划纳入312例,每组156例,以检测组间INR差异≥15%。
- 统计分析采用前后比较的准实验分析及线性回归模型。
关键数值与推荐
- 干预组由经过培训的专家抗凝患者进行「同伴间」联合教学。
- 对照组接受常规临床实践,由护士约每月评估一次。
- INR低于2或高于3的患者评估更频繁。
临床怎么用
- 若有效,该患者间教学干预可融入初级保健抗凝管理流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oral anticoagulant drugs represent an essential tool in the prevention of thromboembolic events. The ones in widespread use are vitamin K antagonists, whose plasma level is monitored by measuring prothrombin time using the international normalized ratio. If its values are out of the recommended range, the patient will have a higher risk of suffering from thromboembolic or hemorrhagic complications. Previous research has shown that approximately 33% of patients keep having values at an inappropriate level. The purpose of the proposed study is to improve the international normalized ratio control results by a joint didactic intervention based on the Junta de Andalucía School for Patients method that will be implemented by anticoagulated patients themselves. METHODS: A randomized controlled trial will be undertaken at primary care centers from one healthcare area in Málaga (Andalusia, Spain). STUDY POPULATION: patients participating in an oral anticoagulant therapy program of vitamin K antagonists. First step: identification of patients in the oral anticoagulation therapy program with international normalized ratio control of the therapeutic level at 65% or less over total time. Second step: patients with international normalized ratio (INR) control figures under 2 or above 3 will be assigned to two different groups: Group 1 or joint intervention group: patients will be instructed in the joint didactic "from peer to peer," by a previously trained and expert anticoagulant patient. Group 2 or control group: the control group will receive the usual clinical practice. They will be evaluated by nurses about once a month, except for cases in which their INR figures are under 2 or above 3, and those patients will be evaluated more frequently. A total of 312 individuals will be required (156 in each group) to detect differences in INR figures equal to or higher than 15% between the groups. STUDY VARIABLES: time on therapeutic levels before and after the intervention; sociodemographic variables; vital signs; the existence of cardiovascular risk factors or accompanying diseases in the clinical records; laboratory test including complete blood counts, bleeding time, and prothrombin time or partial thromboplastin time; and blood chemistry, other prescribed drugs, and social support. A quasi-experimental analytic study with before-after statistical analysis of the intervention will be conducted. Linear regression models will be applied for the main variable results (international normalized ratio value, time on therapeutic level) inputting sociodemographic variables, accompanying diseases, and social support. TRIAL REGISTRATION: ClinicalTrials.gov NCT03647254 . Registered on 27 August 2018.
引用
- Ginel-Mendoza L, Hidalgo-Natera A, Reina-Gonzalez R, et al. Efficacy of a joint didactic intervention using the Junta De Andalucía School for Patients method to control prothrombin time in patients taking anticoagulants: protocol for a randomized controlled trial. Trials. 2021. PMID: 33430922. doi:10.1186/s13063-020-04972-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。